MARKET OPEN: Covid drug trial sets upbeat tone for local trading

MARKET OPEN: Covid drug trial sets upbeat tone for local trading
Paul McBeth
New Zealand’s stock market may be in for a positive start to the week after Wall Street closed stronger on Friday on optimism over a late-stage trial of the Remdesivir drug in treating covid-19. Investor optimism over the economic recovery from the covid-19 pandemic was stoked by drug company Gilead’s news that its antiviral remdesivir product significantly aided the recovery of severely ill patients. Australia’s Therapeutics Goods Administration gave provisional approval for remdesivir to be used in adults with severe covid symptoms. “Gi...

More Markets

NZ sharemarket down after yesterday's gain
Markets Market close

NZ sharemarket down after yesterday's gain

The S&P/NZX 50 Index closed at 11,803.28, down 49.52 points or 0.42%.

Graham Skellern 23 Apr 2024
Santana Minerals requests trading halt on ASX
Markets

Santana Minerals requests trading halt on ASX

The trading halt is pending an announcement on a potential capital raising.

Staff reporters 23 Apr 2024
Sky extends BBC content deal
Markets

Sky extends BBC content deal

The extension will see premium British dramas appear on Sky’s channels.

Daniel Dunkley 23 Apr 2024
NZ sharemarket bounces back 0.5%
Markets Market close

NZ sharemarket bounces back 0.5%

The S&P/NZX 50 Index closed at 11,852.8, up 56.58 points or 0.48%.

Graham Skellern 22 Apr 2024